Pulse Biosciences, Inc Common Stock (DE) (PLSE) is a publicly traded Healthcare sector company. As of May 21, 2026, PLSE trades at $25.66 with a market cap of $1.77B and a P/E ratio of -23.50. PLSE moved +4.49% today. Year to date, PLSE is +78.70%; over the trailing twelve months it is +52.84%. Its 52-week range spans $12.56 to $27.98. Analyst consensus is buy with an average price target of $30.00. Rallies surfaces PLSE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Pulse Biosciences Grants Executive Options and RSUs Under Nasdaq Rule: On Feb. 20, 2026 Pulse Biosciences approved inducement equity awards under Nasdaq Listing Rule 5635(c)(4) granting stock options and restricted stock units to newly hired executives, with awards exercisable at closing market price. Vesting schedules span up to four years, potentially diluting outstanding shares.
| Metric | Value |
|---|---|
| Price | $25.66 |
| Market Cap | $1.77B |
| P/E Ratio | -23.50 |
| EPS | $-1.10 |
| Dividend Yield | 0.00% |
| 52-Week High | $27.98 |
| 52-Week Low | $12.56 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $751.00K |
| Net Income | $-74.57M |
| Gross Margin | 0.00% |
2 analysts cover PLSE: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $30.00.